ArticleTranslational lung cancer research2023

Differential organ-specific tumor response to first-line immune checkpoint inhibitor therapy in non-small cell lung cancer-a retrospective cohort study.

Qi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.